NIH-funded research P30 center grant

Developing advanced viral gene transfer technologies for biomedical research

Official title: Lentivirus Construct Core

Funded at Rhode Island Hospital · NIH-10874446 · Data updated 2026-11-12

This study is all about making it easier for scientists to change genes in cells, which can help them learn more about aging and stem cells, and it's designed to support researchers in Rhode Island and nearby areas.

Quick facts

Grant typeP30 center grant
Study typeNIH-funded research
Funding institutionRhode Island Hospital
NIH-funded
Lab location1 site (Providence, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$208,232
NIH project number5P30GM145500-02
Project IDNIH-10874446 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals involved in biomedical research, particularly those studying genetic disorders, cancer, or aging.

Less likely to help

Patients who are not engaged in research or do not have conditions related to genetic disorders or cancer may not receive direct benefits from this research.

What this research studies

This research focuses on creating and providing access to lentivirus technologies that enable scientists to manipulate genes in cells and tissues effectively. By utilizing advanced methods like CRISPR for gene editing and viral vectors for gene delivery, the project aims to support various biomedical research efforts, particularly in the fields of aging and stem cell research. The goal is to establish a core facility that offers these cutting-edge technologies to researchers in Rhode Island and the surrounding regions, enhancing their ability to conduct impactful studies.

Why it matters

Potential benefit: If successful, this research could significantly improve the tools available for genetic research, leading to advancements in treatments for genetic disorders and cancer.

How similar studies have gone: Other research has successfully utilized viral gene transfer technologies, indicating a strong potential for this approach to yield significant advancements.

Where this research is happening

  • Rhode Island Hospital
    Providence, United States
    Active

Researchers

  • Principal investigator: Liang, Olin D. — Rhode Island Hospital
  • Study coordinator: Liang, Olin D.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.